Robbie Stevens

Robbie Stevens has extensive experience in the medical affairs field, spanning over two decades. Robbie has held various leadership roles in reputable pharmaceutical companies such as Seres Therapeutics, Nabriva Therapeutics, Achaogen, AbbVie, Vertex Pharmaceuticals, Gilead Sciences, and Abbott.

At Seres Therapeutics, Robbie served as Vice President and Head of Medical Affairs, overseeing the medical affairs department. Prior to that, they held the position of Executive Director of Medical Affairs at the same company. At Nabriva Therapeutics, they were the Senior Director of Medical Affairs.

During their time at Achaogen, Robbie built and managed a field-based Medical Scientist team and played a crucial role in the launch of plazomicin. Robbie also collaborated with the VP of Sales to optimize communication and collaboration between Medical Affairs and Commercial departments.

At AbbVie, Robbie served as the Global Director for Hematology/Oncology MSLs and later as the Global Director for Hepatology MSLs. Robbie was responsible for strategic initiatives, recruitment, and training of MSL teams.

During their tenure at Vertex Pharmaceuticals, Robbie led the US and Canada Field Medical team, managing multiple therapeutic areas and launching KALYDECO. At Gilead Sciences, they managed the HIV MSL team and played a key role in the launch of ATRIPLA.

Robbie started their career as a Clinical Research Scientist specializing in HIV MSL at Abbott.

Overall, Robbie Stevens has demonstrated strong leadership, strategic planning, and communication skills throughout their career in the medical affairs field.

Robbie Stevens holds a Doctor of Pharmacy (PharmD) degree from The University of Texas at Austin. Prior to that, they obtained a Bachelor's Degree in Pharmacy from the University of the Sciences in Philadelphia. The start and end years for both degrees are not provided.